Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Uranium American Resources February 27, 2026 Flow Metals February 27, 2026 Prismo Metals to Advance Hot Breccia Toward Drilling Through Strategic Transaction February 27, 2026